Stocks and Investing Stocks and Investing
Tue, November 14, 2023

Andrew Fein Reiterated (STRO) at Strong Buy and Held Target at $16 on, Nov 14th, 2023


Published on 2024-10-28 07:33:55 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Reiterated "Sutro Biopharma, Inc." (STRO) at Strong Buy and Held Target at $16 on, Nov 14th, 2023.

Andrew has made no other calls on STRO in the last 4 months.



There are 5 other peers that have a rating on STRO. Out of the 5 peers that are also analyzing STRO, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Andrew


  • James Shin of "Deutsche Bank" Initiated at Strong Buy and Held Target at $12 on, Thursday, November 9th, 2023
  • David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $12 on, Monday, October 23rd, 2023
  • Jay Olson of "Oppenheimer" Initiated at Buy and Held Target at $10 on, Friday, October 6th, 2023
  • Asthika Goonewardene of "Truist Securities" Reiterated at Strong Buy and Held Target at $25 on, Wednesday, September 6th, 2023
  • Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $17 on, Monday, August 14th, 2023
Contributing Sources